Insulin Resistance in Alström Syndrome: Why It's Severe

Insulin resistance is when cells in the body don't respond well to insulin's signal to take up glucose from the bloodstream. In Alström Syndrome, insulin resistance is among the most severe described in medicine — far more pronounced than in typical type 2 diabetes. This severity affects how diabetes appears, how it's treated, and how related complications develop. This article explains what insulin resistance is, why it's so severe in Alström, and what it means for management.

After eating, the pancreas releases insulin to help cells absorb glucose from the bloodstream. In a healthy person, insulin works efficiently — small amounts trigger appropriate cellular uptake. In insulin resistance, cells don't respond well, so the pancreas releases more and more insulin to achieve the same effect. Eventually:

• Blood glucose levels remain elevated despite high insulin
• The pancreas may eventually fail to keep up
• Type 2 diabetes develops

Insulin resistance is the underlying mechanism behind most adult-onset type 2 diabetes worldwide. In Alström, it's particularly severe.¹

Several factors contribute:

Direct ALMS1 protein effects

The ALMS1 protein appears to play a role in insulin signaling at the cellular level. Research suggests that without functional ALMS1, the pathways that respond to insulin in fat cells, muscle, and liver are impaired. The cellular machinery that should respond to insulin doesn't process the signal efficiently.²

Adipose tissue dysfunction

Fat cells (adipocytes) in Alström don't function normally. The hypothalamic regulation of hunger and energy balance is also affected. This combination drives early childhood obesity, which itself worsens insulin resistance.

Other downstream effects

Severe insulin resistance contributes to:

• High triglycerides
• Acanthosis nigricans (dark skin patches)
• Polycystic ovary syndrome in women
• Fatty liver
• Cardiovascular risk

Clinically, insulin resistance shows up as:

• Elevated fasting insulin — often before glucose is high
• Acanthosis nigricans — dark, velvety skin in folds, signaling years of high insulin
• Hypertriglyceridemia — elevated triglycerides
• Metabolic syndrome features — central obesity, high BP, abnormal lipids
• Eventually, hyperglycemia as beta cells can't keep up

In Alström, fasting insulin levels can be 5–10 times normal even before blood glucose is elevated.³

Adults with Alström often need:

• Insulin doses 5–10 times higher than typical adults with type 2 diabetes
• Multiple injections per day or pump therapy
• High-concentration insulin formulations (U-200, U-300, U-500) in some cases
• Combination therapy with metformin and other agents

These dose levels reflect the severity of the underlying receptor and post-receptor signaling disturbance.

Lifestyle approaches

While Alström-related insulin resistance is biologically driven (not a willpower issue), lifestyle measures still help:

• Regular physical activity improves insulin sensitivity in muscle
• Limiting refined carbohydrates and sugary drinks reduces glucose load
• Weight management within what's achievable for the individual
• Adequate sleep — sleep deprivation worsens insulin resistance
• Stress management — chronic stress raises cortisol, which worsens insulin resistance

Medications

• Metformin — first-line; addresses insulin resistance directly
• GLP-1 agonists (semaglutide, liraglutide) — improve insulin sensitivity, reduce appetite, support weight loss
• SGLT2 inhibitors (empagliflozin, dapagliflozin) — reduce glucose, protect kidney and heart
• Pioglitazone — directly improves insulin sensitivity, but has side effects to consider
• High-dose insulin when other measures aren't enough

Treating related conditions

• Sleep apnea — CPAP improves insulin sensitivity dramatically when sleep apnea is present
• NAFLD — improving fatty liver helps insulin resistance
• PCOS in women — combined treatment helps fertility and metabolism

Dark, velvety patches of skin — typically in the neck, armpits, groin, or knuckles — are a visible sign of significant insulin resistance. Most people with Alström develop acanthosis nigricans by mid-childhood. The patches:

• Aren't dirty (despite their appearance)
• Don't wash off
• Indicate the underlying metabolic state
• Improve when insulin resistance improves (though they may persist)

We cover this in Acanthosis Nigricans in Alström Syndrome.

Severe insulin resistance is itself a cardiovascular risk factor independent of diabetes. People with Alström face cumulative cardiovascular risks from:

• Severe insulin resistance
• Type 2 diabetes
• Hypertriglyceridemia
• Cardiomyopathy (the Alström cardiac involvement)
• Sometimes hypertension

Management involves coordinated cardiovascular and metabolic care.

• Type 2 Diabetes in Alström Syndrome
• Childhood Obesity in Alström Syndrome
• Acanthosis Nigricans in Alström Syndrome
• Diet and Nutrition for Alström Syndrome
• High Triglycerides in Alström Syndrome

April 30, 2026.